Next-Gen Biosafety Masterclass

Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use

SEPTEMBER 10, 2026 in Paris (France)

PathoQuest is pleased to announce the upcoming Next-Gen Biosafety Masterclass: "Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use."

🗓️ September 10, 2026
🕘 8:30 AM – 5:30 PM CET
📍 11 Rue Watt, BioPark, Bâtiment B, 75 013 Paris, France
👤 IN-PERSON

Our preliminary agenda is available:

• Welcome & Strategic Overview
  Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest
• European Regulations on Detection of Viral Adventitious Agents by NGS
  Johannes Bluemel – Head of Viral Safety Section, Paul-Ehrlich-Institut
• Global overview of implementation and regulatory acceptance of NGS for vaccines safety testing
  Laura Viviani – Founder & Consultant, SciEthiQ, Consultant for Animal Free Safety Assessment Collaboration (AFSA)
• NGS in Viral Safety: From Comparison of Methods to Qualification
  Florence Suavet –Head of Development and Validation, PathoQuest
  Marc Eloit – Founder & Scientific Advisor, PathoQuest
• Characterization of Starting Materials Using NGS
  Michael Ruffing – Head of Adventitious Agent Control, Boehringer Ingelheim
• Integrated Use of Viromic and Transcriptomic NGS for Adventitious Virus Testing
  Jens Modrof – Director of Operations, Global Pathogen Safety, Takeda
• Latest Updates & Perspectives on NGS Applications
  Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest
• Industry Case Study (Title TBC)
  Carine Logvinoff – Virology Global Analytical Expert, Sanofi
• Ask the Experts – Interactive Session
  All speakers
• Closing Remarks & Networking Cocktail
  Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest

This agenda is preliminary and subject to refinement.

👉 Free registration is now open.

Seating is limited. Secure your place today.